N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide

C142H189N33O8 — CID 158954963

IUPACN-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide
SMILESCN[C@@H]1CN(c2ccc(C)nn2)C[C@@H]1NC(=O)Cc1ccc(C(C)C)cc1.CN[C@H]1CN(c2ccc(C)nn2)C[C@H]1NC(=O)Cc1ccc(C(C)C)cc1.Cc1ccc(C2(O)CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nn1.Cc1ccc(C2=CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nn1.Cc1ccc(N2CC(NC(=O)Nc3ccc(C(C)C)cc3)C2)nn1.Cc1ccc(N2C[C@@H](N)[C@@H](NC(=O)Cc3ccc(C(C)C)cc3)C2)nn1.Cc1ccc(N2C[C@H](NC(=O)Cc3ccc(C(C)C)cc3)[C@H](N(C)C)C2)nn1
InChIInChI=1S/C22H31N5O.2C21H29N5O.C20H27N5O.C20H26N4O2.C20H24N4O.C18H23N5O/c1-15(2)18-9-7-17(8-10-18)12-22(28)23-19-13-27(14-20(19)26(4)5)21-11-6-16(3)24-25-21;2*1-14(2)17-8-6-16(7-9-17)11-21(27)23-19-13-26(12-18(19)22-4)20-10-5-15(3)24-25-20;1-13(2)16-7-5-15(6-8-16)10-20(26)22-18-12-25(11-17(18)21)19-9-4-14(3)23-24-19;1-14(2)16-5-7-17(8-6-16)21-19(25)24-12-10-20(26,11-13-24)18-9-4-15(3)22-23-18;1-14(2)16-5-7-18(8-6-16)21-20(25)24-12-10-17(11-13-24)19-9-4-15(3)22-23-19;1-12(2)14-5-7-15(8-6-14)19-18(24)20-16-10-23(11-16)17-9-4-13(3)21-22-17/h6-11,15,19-20H,12-14H2,1-5H3,(H,23,28);2*5-10,14,18-19,22H,11-13H2,1-4H3,(H,23,27);4-9,13,17-18H,10-12,21H2,1-3H3,(H,22,26);4-9,14,26H,10-13H2,1-3H3,(H,21,25);4-10,14H,11-13H2,1-3H3,(H,21,25);4-9,12,16H,10-11H2,1-3H3,(H2,19,20,24)/t19-,20+;2*18-,19+;17-,18+;;;/m0101.../s1
InChIKeyJLWVIRASTXEGSC-LNRWAILZSA-N
MW2486.30 g/mol
LogP18.83
Rot. Bonds33

About N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide

N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide (PubChem CID 158954963) has the molecular formula C142H189N33O8 and a molecular weight of 2486.30 g/mol. Its IUPAC name is N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide.

Molecular Properties

Compound NameN-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide
PubChem CID158954963
Molecular FormulaC142H189N33O8
Molecular Weight2486.30 g/mol
Exact Mass2484.54
IUPAC NameN-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide
SMILESCN[C@@H]1CN(c2ccc(C)nn2)C[C@@H]1NC(=O)Cc1ccc(C(C)C)cc1.CN[C@H]1CN(c2ccc(C)nn2)C[C@H]1NC(=O)Cc1ccc(C(C)C)cc1.Cc1ccc(C2(O)CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nn1.Cc1ccc(C2=CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nn1.Cc1ccc(N2CC(NC(=O)Nc3ccc(C(C)C)cc3)C2)nn1.Cc1ccc(N2C[C@@H](N)[C@@H](NC(=O)Cc3ccc(C(C)C)cc3)C2)nn1.Cc1ccc(N2C[C@H](NC(=O)Cc3ccc(C(C)C)cc3)[C@H](N(C)C)C2)nn1
InChIInChI=1S/C22H31N5O.2C21H29N5O.C20H27N5O.C20H26N4O2.C20H24N4O.C18H23N5O/c1-15(2)18-9-7-17(8-10-18)12-22(28)23-19-13-27(14-20(19)26(4)5)21-11-6-16(3)24-25-21;2*1-14(2)17-8-6-16(7-9-17)11-21(27)23-19-13-26(12-18(19)22-4)20-10-5-15(3)24-25-20;1-13(2)16-7-5-15(6-8-16)10-20(26)22-18-12-25(11-17(18)21)19-9-4-14(3)23-24-19;1-14(2)16-5-7-17(8-6-16)21-19(25)24-12-10-20(26,11-13-24)18-9-4-15(3)22-23-18;1-14(2)16-5-7-18(8-6-16)21-20(25)24-12-10-17(11-13-24)19-9-4-15(3)22-23-19;1-12(2)14-5-7-15(8-6-14)19-18(24)20-16-10-23(11-16)17-9-4-13(3)21-22-17/h6-11,15,19-20H,12-14H2,1-5H3,(H,23,28);2*5-10,14,18-19,22H,11-13H2,1-4H3,(H,23,27);4-9,13,17-18H,10-12,21H2,1-3H3,(H,22,26);4-9,14,26H,10-13H2,1-3H3,(H,21,25);4-10,14H,11-13H2,1-3H3,(H,21,25);4-9,12,16H,10-11H2,1-3H3,(H2,19,20,24)/t19-,20+;2*18-,19+;17-,18+;;;/m0101.../s1
InChIKeyJLWVIRASTXEGSC-LNRWAILZSA-N
XLogP18.83
TPSA492.42 Ų
H-Bond Donors12
H-Bond Acceptors31
Rotatable Bonds33
Heavy Atoms183
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002486.30
LogP ≤ 518.83
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1031

Analyze N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide?
The IUPAC name of N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide (CID 158954963) is N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide.
What is the SMILES notation for N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide?
The canonical SMILES for N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide is CN[C@@H]1CN(c2ccc(C)nn2)C[C@@H]1NC(=O)Cc1ccc(C(C)C)cc1.CN[C@H]1CN(c2ccc(C)nn2)C[C@H]1NC(=O)Cc1ccc(C(C)C)cc1.Cc1ccc(C2(O)CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nn1.Cc1ccc(C2=CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nn1.Cc1ccc(N2CC(NC(=O)Nc3ccc(C(C)C)cc3)C2)nn1.Cc1ccc(N2C[C@@H](N)[C@@H](NC(=O)Cc3ccc(C(C)C)cc3)C2)nn1.Cc1ccc(N2C[C@H](NC(=O)Cc3ccc(C(C)C)cc3)[C@H](N(C)C)C2)nn1.
What is the InChIKey of N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide?
The InChIKey is JLWVIRASTXEGSC-LNRWAILZSA-N. The full InChI is InChI=1S/C22H31N5O.2C21H29N5O.C20H27N5O.C20H26N4O2.C20H24N4O.C18H23N5O/c1-15(2)18-9-7-17(8-10-18)12-22(28)23-19-13-27(14-20(19)26(4)5)21-11-6-16(3)24-25-21;2*1-14(2)17-8-6-16(7-9-17)11-21(27)23-19-13-26(12-18(19)22-4)20-10-5-15(3)24-25-20;1-13(2)16-7-5-15(6-8-16)10-20(26)22-18-12-25(11-17(18)21)19-9-4-14(3)23-24-19;1-14(2)16-5-7-17(8-6-16)21-19(25)24-12-10-20(26,11-13-24)18-9-4-15(3)22-23-18;1-14(2)16-5-7-18(8-6-16)21-20(25)24-12-10-17(11-13-24)19-9-4-15(3)22-23-19;1-12(2)14-5-7-15(8-6-14)19-18(24)20-16-10-23(11-16)17-9-4-13(3)21-22-17/h6-11,15,19-20H,12-14H2,1-5H3,(H,23,28);2*5-10,14,18-19,22H,11-13H2,1-4H3,(H,23,27);4-9,13,17-18H,10-12,21H2,1-3H3,(H,22,26);4-9,14,26H,10-13H2,1-3H3,(H,21,25);4-10,14H,11-13H2,1-3H3,(H,21,25);4-9,12,16H,10-11H2,1-3H3,(H2,19,20,24)/t19-,20+;2*18-,19+;17-,18+;;;/m0101.../s1.
What are the key properties of N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide?
N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide has a molecular weight of 2486.30 g/mol, XLogP of 18.83, 33 rotatable bonds, 12 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S,4R)-4-amino-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(dimethylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;4-hydroxy-4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)piperidine-1-carboxamide;N-[(3R,4S)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;N-[(3S,4R)-4-(methylamino)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]-2-(4-propan-2-ylphenyl)acetamide;1-[1-(6-methylpyridazin-3-yl)azetidin-3-yl]-3-(4-propan-2-ylphenyl)urea;4-(6-methylpyridazin-3-yl)-N-(4-propan-2-ylphenyl)-3,6-dihydro-2H-pyridine-1-carboxamide is sourced from PubChem (CID 158954963), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).